Drugs / Evoskin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02334345 | Jan → Nov 2015 | radiodermatitis | University Hospital, Limoges | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Evoskin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02334345 ↗ |
| Route | Topical | “Patients are to apply Evoskin ( topical agent) in the half of the irradiated breast 3 hours after radiothérapy and may be applied again later the same day.” NCT02334345 ↗ |